Peyronnet Rémi, Bollensdorff Christian, Capel Rebecca A, Rog-Zielinska Eva A, Woods Christopher E, Charo David N, Lookin Oleg, Fajardo Giovanni, Ho Michael, Quertermous Thomas, Ashley Euan A, Kohl Peter
Institute for Experimental Cardiovascular Medicine, University Heart Centre Freiburg · Bad Krozingen, Medical School of the University of Freiburg, Germany; Imperial College London, NHLI, Heart Science Centre, UK.
Imperial College London, NHLI, Heart Science Centre, UK; Sidra Medical and Research Center, Qatar Foundation, Qatar.
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):333-343. doi: 10.1016/j.pbiomolbio.2017.09.013. Epub 2017 Sep 18.
The apelin peptide is described as one of the most potent inotropic agents, produced endogenously in a wide range of cells, including cardiomyocytes. Despite positive effects on cardiac contractility in multicellular preparations, as well as indications of cardio-protective actions in several diseases, its effects and mechanisms of action at the cellular level are incompletely understood. Here, we report apelin effects on dynamic mechanical characteristics of single ventricular cardiomyocytes, isolated from mouse models (control, apelin-deficient [Apelin-KO], apelin-receptor KO mouse [APJ-KO]), and rat. Dynamic changes in maximal velocity of cell shortening and relaxation were monitored. In addition, more traditional indicators of inotropic effects, such as maximum shortening (in mechanically unloaded cells) or peak force development (in auxotonic contracting cells, preloaded using the carbon fibre technique) were studied. The key finding is that, using Apelin-KO cardiomyocytes exposed to different preloads with the 2-carbon fibre technique, we observe a lowering of the slope of the end-diastolic stress-length relation in response to 10 nM apelin, an effect that is preload-dependent. This suggests a positive lusitropic effect of apelin, which could explain earlier counter-intuitive findings on an apelin-induced increase in contractility occurring without matching rise in oxygen consumption.
阿片肽被认为是最有效的正性肌力药物之一,在包括心肌细胞在内的多种细胞中内源性产生。尽管在多细胞制剂中对心脏收缩力有积极作用,并且在几种疾病中有心脏保护作用的迹象,但其在细胞水平的作用和机制仍不完全清楚。在这里,我们报告了阿片肽对从小鼠模型(对照、阿片肽缺陷型[Apelin-KO]、阿片肽受体敲除小鼠[APJ-KO])和大鼠分离的单个心室心肌细胞动态力学特性的影响。监测了细胞缩短和松弛最大速度的动态变化。此外,还研究了更传统的正性肌力作用指标,如最大缩短(在机械卸载的细胞中)或峰值力发展(在使用碳纤维技术预加载的辅助等张收缩细胞中)。关键发现是,使用通过双碳纤维技术暴露于不同预负荷的Apelin-KO心肌细胞,我们观察到在10 nM阿片肽作用下舒张末期应力-长度关系的斜率降低,这种效应依赖于预负荷。这表明阿片肽具有正性变时性效应,这可以解释早期关于阿片肽诱导的收缩力增加而氧消耗没有相应增加的违反直觉的发现。